AUTHOREA
Log in Sign Up Browse Preprints

loading page

ANAGRELIDE-INDUCED PERICARDIAL EFFUSION IN A PATIENT WITH ESSENTIAL THROMBOCYTHEMIA
  • +3
  • David Song,
  • Jawad Shabani,
  • Vikash Jaiswal,
  • Kusum Paudel,
  • Arjun Gupta,
  • David Rubinstein
David Song
Icahn School of Medicine at Mount Sinai
Author Profile
Jawad Shabani
Icahn School of Medicine at Mount Sinai
Author Profile
Vikash Jaiswal
AMA School of Medicine
Author Profile
Kusum Paudel
Kathmandu University Hospital

Corresponding Author:doctorkusumpaudel@gmail.com

Author Profile
Arjun Gupta
Icahn School of Medicine at Mount Sinai
Author Profile
David Rubinstein
Icahn School of Medicine at Mount Sinai
Author Profile

Abstract

We present a rare case of anagrelide-induced pericardial effusion that is presented with tamponade physiology in a patient with essential thrombocythemia. After cautiously weighing the risks and benefits of further invasive interventions following an unsuccessful pericardiocentesis, the decision was to stop anagrelide while managing the pericardial effusion medically.

Peer review status:ACCEPTED

13 Dec 2022Submitted to Clinical Case Reports
Show details
Hide details
14 Dec 2022Submission Checks Completed
14 Dec 2022Assigned to Editor
16 Dec 2022Reviewer(s) Assigned
29 Jan 2023Review(s) Completed, Editorial Evaluation Pending
02 Feb 2023Editorial Decision: Revise Major
26 Feb 20231st Revision Received
15 Mar 2023Submission Checks Completed
15 Mar 2023Assigned to Editor
15 Mar 2023Review(s) Completed, Editorial Evaluation Pending
16 Mar 2023Reviewer(s) Assigned
22 Mar 2023Editorial Decision: Revise Minor
29 Mar 20232nd Revision Received
30 Mar 2023Submission Checks Completed
30 Mar 2023Assigned to Editor
30 Mar 2023Review(s) Completed, Editorial Evaluation Pending
07 Apr 2023Editorial Decision: Accept